Myelo Therapeutics GmbH develops innovative treatments in areas of high unmet medical needs.

Management:

	Dirk Pleimes, MD
	Managing Director and Chief Medical Officer. Graduated in medicine and public health from Charité, Humboldt University, Berlin. 13 years of work experience in global medical affairs, clinical development, business development and strategic marketing in pharmaceutical companies based in Germany and the USA. Founder of SCINSPIRE Holding & Consulting GmbH and Treamid Therapeutics GmbH.

Investors:

Supported by: